| answer text |
<p>Ad-hoc meetings of the Joint Committee on Vaccination and Immunisation (JCVI) are
determined by the Chair, in consultation with the secretariat and Department. Ad-hoc
committee meetings are called at key timepoints for the development of advice to the
Department, outside the usual meeting schedule. Public Health England (PHE) provides
the secretariat for the JCVI. Meeting papers are circulated as far in advance as possible.
Given the frequency of meetings at this time, papers may be circulated around one
to two days prior to the meeting.</p><p>The JCVI does not commission research or organisations.
Data have been provided to the Committee from a variety of organisations, including
OpenSAFELY, QCOVID, University of Oxford, industry representatives and PHE. Published
or pre-publication academic research is also considered by the committee. The SARS-CoV-2
for Cancer Patients study has been provided to the JCVI’s members. The JCVI is considering
this paper and other academic research into immune responses to COVID-19 vaccines.
The JCVI has not commissioned an external review of this paper. Their considerations
and advice will be published in the minutes of the meetings and in the Green Book:
Immunisation against infectious disease, in due course.</p><p> </p>
|
|
